Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Mirabegron Versus Tamsulosin Versus Solifenacin for Treatment of Ureteral Stents-Related Symptoms: a Randomized Controlled Trial

NCT04325880 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT04325880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04325880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Mirabegron Versus Tamsulosin Versus Solifenacin for Treatment of Ureteral Stents-Related Symptoms: a Randomized Controlled Trial
Lead sponsor
Mansoura University
Phase
Phase 3
Overall status
Unknown status
Start date
December 1, 2021
Completion date
July 1, 2022
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stent related symptoms, ureteral stent